DentistryIQ recently posed the three questions to ask yourself when making difficult technology decisions for your dental practice. While you can’t put a price on providing your patients with a treatment option they prefer, it’s also important to take your practice’s financial health into consideration. Below, we answer each of the questions to explain why the PerioLase MVP-7 is a winner for your patients, practice and pocketbook.
How does it maintain or improve predictability?
The LANAP protocol, performed only by the PerioLase MVP-7, is backed by clinical and scientific results as well as two human histological studies to effectively treat periodontitis. Once trained at Laser Bootcamp, LANAP clinicians take their knowledge back to their own practices and begin treating their patients.
When compared to traditional osseous surgery, the results are as predictably positive if not better using the LANAP and LAPIP protocols to save teeth and/or implants. Plus, the LANAP protocol boasts the ability to regrow lost tissues — complete with an FDA clearance for True Periodontal Regeneration — something traditional surgery cannot.
How does it increase efficiency?
The PerioLase MVP-7 increases efficiency in ways that both practitioners and patients can appreciate. Patients treated with the LANAP protocols are treated in just two appointments; after which, they only come back for routine checkups. The LAPIP protocol is a same-day treatment, meaning if you already have the patient in the chair, you can treat them if needed. Patients love the quick treatment, and doctors are able to see other patients during time they otherwise would have spent treating one patient using traditional surgery methods. For general practitioners, this can also mean the ability to schedule patients that they might have otherwise referred to a periodontist or specialist.
Additionally, doctors report that the ease of use of the laser has reduced wear and tear on their body, meaning less aches and pains that are generally associated with more invasive surgeries.
What is the return on investment?
How are you measuring ROI — in terms of personal satisfaction, patient satisfaction or tangible cash coming back into your practice? Regardless of how you choose to look at it, the PerioLase MVP-7 is an investment that will impress on all fronts. Patient acceptance sits at around 90% — far above the rate for traditional surgery — and the PerioLase MVP-7 could increase your practice’s profits by $100,000 a year. Add these factors to the fulfillment of treating patients with cutting-edge, best-in-dentistry technology that can predictably regenerate bones and tissue lost to periodontitis and you have 10s across the board.
But don’t take our word for it. Dr. Ryan Tracy, DMD is a LANAP clinician who was able to get 503% ROI in the first year on his PerioLase MVP-7 investment.
Now that you have some insight into how the PerioLase MVP-7 can fit into each of these very valid scenario questions, you can make an informed decision about purchasing one for your practice. Don’t forget that purchase of PerioLase MVP-7 comes with world-class hands-on training with industry experts, or that it can perform a variety of other surgeries and functions beyond treating periodontitis and periimplantitis.
For even more research and educational resources, check out our Research Library and Webinar section. Last but not least — listen to what real life doctors and patients who treat or have been treated with the LANAP and LAPIP protocols have to say.
IALD Instructor and LANAP clinician Suresh Goel, DDS weighs in below on how to successfully integrate new technology into your practice: